American Thoracic Society 2012 Sessions

Home Attendees Exhibitors Speakers Program Site Search

m

ia

s

2012 Session TitlesThe ATS International Conference Program offers the latest in pulmonary, critical care and sleepmedicine for ATS members and other physicians, scientists and healthcare professionals.

Following are lists of postgraduate courses, scientific symposia, track sessions, seminars andworkshops offered at ATS 2012 • San Francisco.

FRIDAY, MAY 18

POSTGRADUATE COURSES8:00 am – 4:00 pm

PG1 Pulmonary Adaptive Immunity: More Than Just Crossing Your T's

PG2 Grant Fundamentals For Clinical, Community, And Public Health Researchers

PG3 Lung Cancer: State Of The Art In 2012

PG4 Intensive Care Unit Monitoring

PG5 Pulmonary And Critical Care Reviews: Built Around ABIM 2011 Modules (Updates) InPulmonary And Critical Care

PG6 Incorporating Ultrasound And Echocardiography Into Intensive Care Unit Practice

PG7 Epigenetics Of Lung Diseases

PG8 Difficult Clinical Problems In Pulmonary Infections

PG9 The Cellular Foundation Of Pediatric Respiratory Disease

PG10 Sleep Disordered Breathing And Associated Co-Morbidities In Children: From Bench ToBedside

PG11 New Science In The Comprehensive Management Of The Chronic ObstructivePulmonary Disease Patient

PG12 Case-Based Pulmonary Function Test (PFT) Interpretation: The Foundations

PG13 What’s New In Obstructive Sleep Apnea And Cardiovascular Disease?

PG14 Leadership Workshop: Developing Skills To Advance Your Career And Improve YourWork Environment. Day 1

SATURDAY, MAY 19

POSTGRADUATE COURSES8:00 am – 4:00 pm

PG15 Enhancing Patient Centered Care And Improving Outcomes Through MotivationalInterviewing: A Hands On Course- CANCELLED

American Thoracic Society http://conference.thoracic.org/2012/Programs/session-titles.php

1 of 24 5/31/2012 5:25 PM

PG16 Thoracic Imaging

PG17 Management Of Interstitial Lung Disease: A Case-Based Approach

PG18 Exacerbations Of Chronic Obstructive Pulmonary Disease: Measurement, Mechanisms,Modeling And Management

PG19 Novel Approaches To Investigate Occupational And Environmental Causes In CommonLung Diseases

PG20 Host Defense Mechanisms In Pulmonary Infection

PG21 The Physiologic Basis Of Pediatric Respiratory Diseases

PG22 Update In Pulmonary Arterial Hypertension: What's New, What's Now

PG23 Update On Venous Thromboembolism

PG24 Cardiopulmonary Exercise Testing (CPET): An Evidence And Case-Based Update 2012

PG25 Master Physiology Class: Common Pulmonary Diseases From A PhysiologicPerspective

PG26 Current And Emerging Treatments For Sleep Disordered Breathing

PG27 Mastering Clinical Teaching Skills For Pulmonary And Critical Care

PG28 Leadership Workshop: Developing Skills To Advance Your Career And Improve YourWork Environment. Day 2

PG29 American Thoracic Society Bronchoscopy Course

SUNDAY, MAY 20

HANDS-ON LUNG BIOPSY SKILLS WORKSHOP7:00 am - 12:00 pm

H1 Hands-On Lung Biopsy Skills Workshop: Mutational Testing In The Era Of PersonalizedNSCLC Therapy

YEAR IN REVIEW8:15 am – 10:15 am

A1 Clinical Year In Review 1

CLINICAL TOPICS IN PULMONARY MEDICINE8:15 am – 10:45 am

A2 Evaluation Of Interstitial Lung Disease: More Bang For Your Buck

A3 Fellows Case Conference

CRITICAL CARE TRACK8:15 am – 10:45 am

A4 What Do You Do Now? Clinical Challenges At The Edge Of The Evidence

SCIENTIFIC SYMPOSIA8:15 am – 10:45 am

A5 Dyspnea Update And The Road Ahead

A6 The Price Of Progress: Lung Injury Before And After Pediatric Lung Transplantation


2 of 24 5/31/2012 5:25 PM

A7 Airway Remodeling And Hyperresponsiveness In Asthma: What Are They And What CanWe Do About Them?

A8 ARRA-Funded Lung Stem And Progenitor Cell Projects

A9 Epigenetics At The Crossroads: The Intersection Between The Lung And TheEnvironment

A10 HIV-Associated Pulmonary Complications In The Era Of Antiretroviral Therapy

A11 Adult Cystic Fibrosis: The Essentials

A12Discussion On The Edge: Reports Of Recent Pulmonary Research Published In The New EnglandJournal Of Medicine Or The Journal Of The American Medical Association

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS8:15 am – 10:45 am

A13 Advances In COPD Pathogenesis And Exacerbation Susceptibility

A14 Tuberculosis Host Defense

A15 Airway Responses To Respiratory Viral Infection

A16 The Matrix In Control: Pathobiology Driven By Matrix Remodeling And Rigidity

A17 Pathogenic Mechanisms Of Acute Lung Injury

A18 Obstructive Sleep Apnea: Interventions And New Associations

A19 Novel Insights And Novel Approaches: Late Breaking Abstracts

A21 First Responders: Mucosal Innate Immunity

A22 Psychosocial Factors Associated With Respiratory Health Outcomes

A23 Novel Technology In Interventional Pulmonology

A24 Clinical Sepsis

A25 Predicting Development And Outcomes In Acute Lung Injury

A26 Work-Related Lung Disease: Clinical And Epidemiological Approaches

A27 Health Effects Of Nanoparticles

A28 Lung Development: Bench To Bedside

A29 Pathogenesis Of Pulmonary Hypertension

A30 Pulmonary Vices: Cigarette Smoke, Alcohol And Oxidative Stress Responses Of TheLung

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS8:15 AM – 4:30 PM

A31 Pathogenesis Of COPD And Emphysema In Mice And Men

A32 Smoke-Related Alterations In Lung Biology

A33 Acute Lung Injury

A34 New Insights Into Sarcoidosis


3 of 24 5/31/2012 5:25 PM

A35 Recent Advances In Phagocyte Biology

A36 Cytokines And Chemokines In Airways Disease

A37 Lipids In Lung Diseases

A38 Microbial Influences On Asthma And COPD

A39 Improving Quality In The Intensive Care Unit

A40 The Economic Burden Of Respiratory Disease And Cost- Effectiveness Of Treatments

A41 COPD: What's The Score?

A42 COPD: Phenotypes And Outcomes

A43 COPD: Functional Assessment And Exercise

A44 Topics In Benign And Malignant Pleural Disease

A45 Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases

A46 Intensive Care Unit Management And Rapid Response: Provider And Patient Outcomes

A47 Diagnostic Techniques And Monitoring

A48 Mechanical Ventilation

A49 Air Pollution: Respiratory And Novel Health Effects

A50 Health Effects Of Indoor Air Pollutants

A51 Diet, Overweight, Diabetes And Lung Disease

A52 Differentiating Health Care Associated Pneumonia From Community AcquiredPneumonia

A53 Epidemiology, Risk Factors, And Outcomes Of Respiratory Infections

A54 Assessing Severity Of Disease In Patients With Community Acquired Pneumonia

A55 Lung Development And Chronic Lung Disease Of Prematurity

A56 Pediatric And Neonatal Critical Care

A57 Pulmonary Barriers To Edema Formation

A58 Clinical Evaluation Of Pulmonary Hypertension

A59 Fibroblast Biology Reloaded

A60 COPD: Omics

A61 Antifibrotics And Therapeutic Targets In Experimental Lung Fibrosis

A62 New Insights In Acute Lung Injury: In Vivo And In Vitro

A63 New Concepts In The Alveolar Surfactant Structure And Function

A64 Local And Systemic Effects Of Smoke Exposure


4 of 24 5/31/2012 5:25 PM

A65 Lung Imaging: Physiology And Technology

A66 Modeling, Mechanics And Gas Exchange

A67 Acute Lung Injury And Acute Respiratory Distress Syndrome: Biological Mechanisms

A68 Tissue Remodeling In The Lung

A69 Neural Control Of The Airway

A70 Sleep Disordered Breathing: Cardiovascular And Metabolic Aspects

WORKSHOPS11:30 am – 1:00 pm

WS1 Endobronchial Ultrasound Workshop

WS2 Mycobacterial And Fungal Diagnostics

SESSIONS BY OTHER ORGANIZATIONS12:00 pm – 1:00 pm

L1 Tips From The Other Side: Making Grant Applications Attractive To The National InstituteOf Nursing Research

L2 Pulmonary Update From The U.S. Food And Drug Administration

L3 NASA’S Satellites And Their Use In Studying The Environement And Diseases

L4 The NIAID Human Immunology Project Consortium: Influenza And Systems Biology

L5 Update From CDC's TB Trials Consortium (TBTC) And TB Epidemiologic StudiesConsortium (TBESC)

L6 Infant Study Of Inhaled Saline In Cystic Fibrosis (ISIS)

L7 The Lung HIV Microbiome Project: Validation, Healthy Volunteers, And Diseased States

L8 NHLBI Childhood Asthma Research And Education (CARE) Network: New StudyFindings

L9 Effects Of Adenotonsillectomy On Health Outcomes In Children With Sleep Apnea:Results From The Childhood Adenotonsillectomy (CHAT) Study

L26 Developmental Origins of Asthma: Primary Prevention Strategies

MEET THE PROFESSOR SEMINARS12:00 pm – 1:00 pm

MP401 Managing Asthma Phenotypes For The Clinician

MP402 Does Addressing Health Literacy Improve Health Outcomes?

MP403 Prevention Of COPD Exacerbations: Current And Novel Approaches

MP404 Autoantibodies And Lung Disease

MP405 Bronchiectasis: Case Based Approach To Diagnosis And Treatment

MP406 Diagnosing And Managing Interstitial Lung Disease In The Elderly Patient

MP407 Advances In Adult Cystic Fibrosis For The Non-CF Physician


5 of 24 5/31/2012 5:25 PM

MP408 Role Of The Pulmonary Intensivist In The Paradigm Of Accountable Care Organizations

MP409 Malignant Pleural Effusion: What Are My Options?

MP410 Achieving Zero CLABSI Rates In Your ICU

MP411 Tuberculosis And The TNF-Alpha Inhibitors

MP412 Non-Pharmacologic Intervention For Insomnia Co-Morbid With Chronic Illness

MP413 Pediatric Mechanical Ventilation

MP414 Surgical Risk Assessment And Management In The Patient With PulmonaryHypertension

MP415 The Do's And Don'ts Of A K08 Application

MP416 Obesity And Asthma Overlap: Insight Into Pathophysiology And Treatment Strategies

MP417 Developing New ATS/ERS Recommendations For Methacholine Challenge Testing

MP418 Women And Sleep

THEMATIC SEMINAR SERIES12:00 pm – 1:00 pm

TSS1 Chronic Obstructive Pulmonary Disease

OUTSTANDING RESEARCH PROGRAM2:00 pm – 4:30 pm

A81 Scientific Breakthroughs Symposium: Biomarkers For Lung Disease: The Cutting Edge

CLINICAL TOPICS IN PULMONARY MEDICINE2:00 pm – 4:30 pm

A82 Emerging Science Of Non-Cystic Fibrosis Bronchiectasis

A83 Great Cases: Clinical, Radiologic And Pathologic Correlations By Master Physicians

SCIENTIFIC SYMPOSIA2:00 pm – 4:30 pm

A85 The IL33/ST2 Axis: New Biology And New Potential Targets In Asthma

A86 Neonatal Origins Of Adult Pulmonary Disease

A87 Arrhythmogenesis And Cardiac Disease In Sleep Disordered Breathing: MechanismsAnd Clinical Implications

A88 Microparticles: Small Wonders Or A Big Deal In Pulmonary Injury And Disease?

A89 Novel Inflammatory And Repair Pathways In Chronic Obstructive Pulmonary Disease

A90 Pediatric Non-Invasive Ventilation

A91 Advances in Lung Transplant

A111 Drugs, Regulatory Agencies and Guidelines: The Challenge of Idiopathic PulmonaryFibrosis

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS2:00 PM – 4:30 PM


6 of 24 5/31/2012 5:25 PM

AP

Highlight

A92 Severe Asthma: Present And Future

A93 Identifying Risk Factors And Potential Interventions For Asthma Adherence

A94 The New Biology Of Sepsis

A95 Hygiene Hypothesis Revisited

A96 Transitions In Health Care Setting, Disease Management, And Disease State

A97 Modeling Remodeling: How Disease Affects The Airways

A98 Nanotech Meets The Lung

A101 Pharmacological Treatment Of Copd: Old And New

A102 Long-Term Outcomes After Critical Illness

A103 Health Services Research And Administrative Databases

A104 Tuberculosis In Vulnerable Populations

A105 Evaluation Of Pediatric Lung Diseases

A106 Advances In Diagnosis And Treatment Of Pulmonary Embolism

A107 Assessment, Exercise Training And Outcomes

A108 Airways Hyperresponsiveness: Causes And Treatments

A109 Upper Airway Control, Structure And Function

A110 Emerging Insights Into Obstructive Lung Disease: Late Breaking Abstracts

MONDAY, MAY 21

SUNRISE SEMINARS7:00 am – 8:00 am

SS101 Eosinophils: Friend Or Foe In Pulmonary Disease?

SS102 Pulmonary Hypertension In Interstitial Lung Disease

SS103 Diagnosing And Treating Collagen Vascular Associated Interstitial Lung Disease

SS104 Optimizing Efficiency And Yield With EBUS-TBNA

SS105 What Is My Pathologist Trying To Tell Me?

SS106 Optimizing The Patient For Lung Transplantation

SS107 Acute COPD Exacerbation Phenotypes: Recognition And Treatment

SS108 Liberation From Mechanical Ventilation: Beyond Weaning Parameters

SS109 Real-World Spirometry: Pitfalls That Falsely Elevate (Or Reduce) Results

SS110 Infectious Etiologies Of Asthma And Asthma Exacerbation

SS111 Dyspnea Crisis: Translation Into Practice


7 of 24 5/31/2012 5:25 PM

SS112 Management Of Emerging Drug-Resistant Strains Of Bacteria That Cause Pneumonia InChildren

SS113 Pulmonary Complications Of Liver Disease

SS114 Contemporary Techniques For Epigenetic And Epigenomic Studies In Lung Disease

SS115 Practical Integration Of Novel And Established Imaging Techniques For The DiagnosisAnd Staging Of Lung Cancer

SS116 The Use Of Image Analysis In Quantifying The Pathology Of Lung Diseases

SS117 What The Pulmonologist Should Know About Sleep In Respiratory Disease

THEMATIC SEMINAR SERIES7:00 am – 8:00 am


TSS2 Drug-Induced Lung Disease

HANDS-ON LUNG BIOPSY SKILLS WORKSHOP7:00 am - 12:00 pm

H2 Hands-On Lung Biopsy Skills Workshop: Mutational Testing In The Era Of PersonalizedNSCLC Therapy


B1 Clinical Year In Review 2


B2 Chronic Obstructive Pulmonary Disease Exacerbations: Lessons Learned From ClinicalTrials

B3 Pushing The Envelope: Reevaluating The Criteria For Lung Transplant CandidateSelection


B4 An Ounce Of Prevention In Critical Care


B5 Idiopathic Interstitial Pneumonias/Pulmonary Fibrosis: Is 'Idiopathic' Truly 'Idiopathic'?

B6 Controversies In The Treatment Of Childhood Asthma: A Pro-Con Debate

B7 Controversies In The Diagnosis And Management Of Obstructive Sleep Apnea: CuttingEdge Debates

B8 The Updated ATS/ERS Statement On Pulmonary Rehabilitation

B9 Targeting The Alveolome: Intercellular Crosstalk In Alveolar Injury, Repair, And Therapy

B10 Non-Tuberculous Mycobacteria Update: Guidelines Plus 5

B11 Probing The Lung Microbiome In Health And Disease


8 of 24 5/31/2012 5:25 PM

AP

Highlight

B12 Improving Care For Severe Sepsis In Resource-Limited Settings

B13Discussion On The Edge: Reports Of Recent Critical Care Research Published In The Journal OfThe American Medical Association Or The New England Journal Of Medicine


B14 Control Of Innate And Adaptive Immunity In The Lung

B15 Clinical Outcomes Research Methodology

B16 Cystic Fibrosis: Novel Therapies And Outcome Measures

B17 How Bad Is Traffic Pollution? Health Effects And Interventions

B18 Rare Pediatric Lung Disease: Expanding Our Understanding

B19 Update In Clinical Trials Of Pulmonary Arterial Hypertension

B20 Emerging Approaches To Respiratory Infections: Late Breaking Abstracts

B21 Genetics Of Asthma

B22 Advances In The Treatment Of Lung Cancer

B23Outcomes, Health Services And Patient-Centered Research In The Intensive CareUnit

B24 Process Improvement: Impact On Outcomes Of Patients With Pneumonia

B25 Smoking Across The Research Spectrum: Symptoms, Genetics, And Quality Of Life

B26 Pulmonary Vascular Signaling In Pulmonary Hypertension

B27 Balancing Act: Novel Functions Of The Protease And Antiproteases In The Lung

B28 Emerging Biomarkers Of Complex Lung Diseases

B29 The Lung On The Border Between Order And Chaos

B30Mechanisms Of Muscle Weakness In Critical Illness: Translating Basic Science To TheBedside


B31 Environmental Exposures That Influence Lung Function

B32 Test Your Diagnostic Skills: Interesting Cases

B33 Asthma Therapy: Novel Approaches

B34 Inflammatory Mechanisms In Asthma

B35 Pathogenesis And Clinical Issues In Cystic Fibrosis

B36 Airway Hyperresponsiveness

B37 New Insights Into Asthma And COPD Treatment

B38 Barriers To Self-Management And Access To Care And Strategies To Overcome Them


9 of 24 5/31/2012 5:25 PM

B39 Current Practices In Medical Education: Residents To Practicing Physicians

B40 Lung Volume Reduction In COPD

B41 COPD: Pharmacological Treatment

B42 Case Reports: General Pulmonary

B43 Endobronchial Ultrasound: Diagnostic Applications

B44 Advances In The Diagnosis And Treatment Of Sarcoidosis

B45 Exacerbations Of COPD: Prevention, Treatment And Outcomes

B46Acute Respiratory Distress Syndrome And Ventilator Induced-Lung Injury: Bench ToBedside Advances

B47 Intensive Care Unit Physiotherapy And Weaning: Mind Over Muscle?

B48 Non-Invasive Ventilation

B49 Non-Pulmonary Critical Care

B50 Clinical Trials In The Intensive Care Unit

B51 Air Pollution And Temperature: Cardiovascular Effects

B52Recognizing Occupational And Environmental Lung Disease: Clinical And ExposureAssessment

B53 Asthma Epidemiology: Trends And Risk Factors

B54 Tuberculosis In Special Populations

B55 Host Defense In Pulmonary Infection And Tuberculosis

B56 Pathogenesis And Host Response To Fungal Lung Infections

B57 Improving Outcome In Tuberculosis

B58 Tuberculosis Education And Surveillance

B59 Asthma: Devices, Adherence, And Health Outcomes

B60 Nursing In Pulmonary And Critical Care

B61 Pediatric Asthma

B62 Pediatric Clinical Cases

B63 Experimental Models In Pulmonary Hypertension I

B64 Right Ventricle In Pulmonary Vascular Disease

B65 Epigenetic Regulation Of Lung Cell Function

B66 The Fibroblast Pool On The Move: Derivation And Targeting

B67 Ion Transport In Lung Cells: Impact On Lung Function And Disease

B68 Lung Structure And Growth


10 of 24 5/31/2012 5:25 PM

B69 Airway Structure And Function

B70 Sleep Disordered Breathing: Pathophysiology


WS3 Career Development Workshop: Grantsmanship Skills For Basic Science AndTranslational Researchers: What Happens During Grant Review?

WS4 Case Based Approach To Diagnosing And Treating Patients With Non-TuberculousMycobacterium Lung Infections


L10 Challenges And Progress In Understanding Community-Acquired Pneumonia: : TheCDC Epic Study

L11 Fogarty International Center Research And Research Training Opportunities

L12 The Role Of The Microbiome And Epigenetics In Inner City Asthma

L13 Get To Know NIGMS The National Institute Of General Medical Sciences

L14 NIOSH Update On Classifying Digital Chest Images Of Pneumoconioses

L15 Update On NHLBI ARDS Network: Ancillary Studies

L16 COPD-Clinical Research Network Clinical Trials Update: Azithromycin In ExacerbationsPrevention And Response To Pneumococcal Vaccinations

L17 Findings From NHLBI Severe Asthma Research Program: Dissecting Heterogeneity OfSevere Asthma

L27 COPD Guidelines and Treatment Initiatives Update


MP501 Comprehensive Management Of The Patient With Idiopathic Pulmonary Fibrosis

MP502 Lung Cancer Staging In 2012

MP503 Clinical Problems In Sarcoidosis

MP505 Pulmonary Diseases Associated With Elevated IGE

MP506 Coding For Pulmonary Function Testing: New Codes For Old Tests

MP507 Pulmonary Artery Catheterization For The Pulmonologist: Practical Tips

MP508 Predictably Irrational: Revealing The Hidden Forces That Drive End Of Life Decisions

MP509 Pulmonary Infections After Disasters

MP511 Measurement Issues In COPD

MP512 Viral Infections And Childhood Asthma

MP513 Management Of The Patient With A Submassive Pulmonary Embolism: EvolvingConcepts


11 of 24 5/31/2012 5:25 PM

AP

Highlight

MP514 Maintaining Quality In Pulmonary Rehabilitation

MP515 The Process Of Writing And Reviewing A Scientific Article

MP516 Gene Therapy For Lung Diseases: A Postponed Dream Whose Time Has Come?

MP517 Similarities And Differences In Asthma And COPD: Are They Real?

MP518 A Practical Approach To Improving Adherence To Positive Airway Pressure Therapy InPatients With Obstructive Sleep Apnea




YEAR IN REVIEW2:00 pm – 4:30 pm

B81 Pediatric Year In Review


B82 The Many Faces Of Bronchiolitis Obliterans: New Insights From Occupational MedicineTo Human Transplantation

B83 Immunotherapy For Lung Cancer And Mesothelioma

CRITICAL CARE TRACK2:00 pm – 4:30 pm

B84 Extracorporeal Gas Exchange: Respiratory Failure And Beyond


B85 Divergent Roles Of Antigen Presenting Cells In Lung And Health Disease

B86 Targeting The Extracellular Matrix: Detecting And Treating Fibrotic Diseases

B87 Everything You Always Wanted To Know About Your Patient (But Were Afraid To Ask)

B88 Work-Exacerbated Asthma: New Developments In Clinical Approach, Epidemiology,And Prevention

B89 Ubiquitination And Proteolysis In Respiratory Disease

B90 Going For The Cure: The Mycobacteria Case

B91 Career Development Symposium: The Evolution of Academic Medicine

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS2:00 pm – 4:30 pm

B92Asthma Phenotypes: Better Understanding Of Asthma And Rationale ForTherapy

B93 Clinical Trials In Idiopathic Pulmonary Fibrosis And Sarcoidosis

B94 Neuromuscular, Cognitive And Psychiatric Issues In The Intensive Care Unit


12 of 24 5/31/2012 5:25 PM

AP

Highlight

B95 Bench To Bedside Advances In Bronchiectasis

B96Mechanisms And Markers Of Pulmonary Endothelial Barrier Disruption AndRepair

B97 Pulmonary Rehabilitation: The Best Of The Best

B98 Novel Approaches To Lung Imaging

B101 Pathogenesis Of Acute Lung Injury

B102 COPD: Challenges Affecting Diagnosis, Treatment, And Health Outcomes

B103 COPD: Mechanisms Of Disease Progression And Exacerbation

B104 Lung Transplantation: Patient Selection, Complications, And Outcomes

B105 Devices And Monitoring In The Intensive Care Unit

B106 New Developments In Lung Disease Genetics

B107 Biomarkers And Predictors Of Outcomes In Pulmonary Hypertension

B108 Diagnostic And Therapeutic Approaches In Sleep Apnea

B109Sleep Disordered Breathing And Cardiovascular Disease: Of Rodents AndHumans

B110Genomics, Metabolomics, And Epigenetics In Lung Disease: Late BreakingAbstracts

TUESDAY, MAY 22


SS201 Targeting The Protease/Antiprotease Imbalance In COPD

SS202 Practical Applications Of Technology In Medical Education

SS203 Management Of Extra-Pulmonary Sarcoidosis: Neurologic, Cardiac, Hepatic,Hypercalcemia And Fatigue

SS204 Lung Transplant 101

SS205 The Bronchoscopist's Evolving Role In Lung Cancer Diagnosis And TherapeuticDecisions

SS206 The Art Of Prognostication: Understanding The Impact Of Comorbidities On PatientOutcome

SS207 Key Concepts In Cost Effectiveness And Decision Analysis: A Practical Approach ForThe Practicing Clinician

SS208 COPD, Asthma, Or Something In Between?

SS209 The Use Of Non-Physician Providers In The ICU

SS210 Hantavirus Cardiopulmonary Syndrome

SS211 Flexible Bronchoscopy In The Pediatric Intensive Care Unit

SS212 Pulmonary Hypertension Due To Left Heart Disease: Prognosis And Management


13 of 24 5/31/2012 5:25 PM

SS213 Pulmonary Rehabilitation For The Surgical Patient

SS214 Of Mice And Men: Therapeutic Implications Of Preclinical Models Of IPF

SS215 Obesity And Asthma: What Can We Learn From Animal Models?

SS216 Too Tired For 18 Wheels: Case Studies Of Sleep Apnea In Commercial Truck Drivers

THEMATIC SEMINARS SERIES7:00 am – 8:00 am



C1 Clinical Year In Review 3


C2 Pulmonary Fibrosis: When It’s Not Idiopathic Pulmonary Fibrosis

C3 Newly Recognized And Emerging Lung Diseases


C4 Acute Kidney Injury In The Intensive Care Unit


C5 Revisiting The IDSA-ATS Community-Acquired Pneumonia Guidelines: 5 Years Older,But Any Wiser?

C6 Inflammation And Altered Metabolism In Pulmonary Hypertension

C7 Developmental Control Of Respiratory Structure And Function During The Course OfLife

C8 No Pain No Gain: Will Upper-Airway Exercise Training/Electrical Stimulation Work ForSleep Apnea?

C9 Pulmonary Rehabilitation Across The Spectrum Of Illness For Patients With ChronicObstructive Pulmonary Disease

C10 Implementing Lung Cancer Screening: Moving From RCTS To The Real World

C11 Imag(in)e The Lung: New Methodologies For Real-Time Visualization Of The Lung InExperimental Animals And Patients

C12 Tobacco Dependence In Pediatrics: What Can Be Done To Help Our Children AndTheir Parents?


C13 Mechanisms Involved In Exacerbation Of Asthma And COPD

C14 Clinical Trials In Critical Care

C15 Predictors For COPD Progression And Outcomes


14 of 24 5/31/2012 5:25 PM

AP

Highlight

C16 Best Of Pediatrics

C17Cellular And Molecular Signaling In The Pulmonary Endothelium Regulating ProliferationAnd Programmed Cell Death

C18 Emerging Pathways And Secondary Hits In Pulmonary Fibrosis

C21 Asthma Biomarkers

C22 Asthma Therapy

C23 COPD Comorbidities: Expanding The Horizons

C24 This Can Be Done Better: Quality, Safety And Process Improvement In Critical Care

C25 Advances In Non-Tuberculous Mycobacteria: Non-Tuberculous Mycobacteria Disease

C26 From PCP To COPD: Pulmonary Complications Of HIV Infection

C27 Evaluation And Management Of Difficult Asthma Populations

C28 Diagnosis And Treatment Of Pulmonary Hypertension

C29 Fat Signals: Crosstalk Between The Adipose Tissue And The Lung

C30 The Role Of The Smooth Muscle Cell In Airway Disease


C31 Regulation Of Lung Inflammation

C32 Refractory Asthma

C33 Rhinitis, Sinusitis And Other Co-Morbidities

C34 Asthma Therapy: New Findings On Established Treatments

C35 Bacterial Pneumonia

C36 Lung Epithelium, Submucosal Glands And Smooth Muscle

C37 Mediators Of Asthma And Allergic Lung Disease

C38 Advances In Asthma And COPD Screening And Monitoring

C39 COPD Evaluation: Imaging

C40 COPD: Alpha 1 Antitrypsin

C41 Outcomes In Interstitial Lung Disease

C42 Case Reports: Tumors

C43 Lung Cancer: Diagnosis, Staging, Treatment And Outcomes

C44Lymphangioleiomyomatosis And Other Cystic Lung Diseases: Clinical Features AndEvolving Therapies

C45 Exacerbations Of COPD: Susceptibility And Pathogenesis


15 of 24 5/31/2012 5:25 PM

AP

Highlight

C46 Idiopathic Pulmonary Fibrosis: Pathogenesis And Comorbidities

C47 Topics In Transplant Medicine

C48 Bronchoscopy For Benign Disorders

C49 Interstitial Lung Disease: Supplemental Oxygen And Other Therapies

C50 COPD: Biomarkers

C51 Comorbidities In COPD

C52 COPD Pathogenesis: Human Studies

C53 COPD Pathogenesis: In Vitro And In Vivo Studies

C54 Case Reports: Interventional Pulmonology

C55 Interstitial Lung Disease: Diagnostic And Therapeutic Considerations

C56 Pulmonary And Non-Pulmonary Critical Care: Great Cases!

C57 Cardiopulmonary Interactions In The Intensive Care Unit

C58 Environmental Exposures: Mechanisms

C59 Occupational And Environmental Lung Disease

C60 Advances In Diagnosis Of Active Tuberculosis Disease

C61 Immunodiagnostics For Latent Tuberculosis Infection And Tuberculosis

C62 Experimental Models In Pulmonary Hypertension II

C63 Management Of Pulmonary Hypertension

C64 Pulmonary Vascular Structure, Function, And Signaling

C65 Peripheral Muscle Dysfunction

C66 Integrated Care And Pulmonary Rehabilitation

C67 Translational "Omics" Discoveries In Lung Disease

C68 Old And New Pathways To Pulmonary Fibrosis

C69 Cellular Signaling Of Oxidative Stress

C70 Repair And Regeneration: Stem Cell Functions And Applications

C71 Major Impact Of Micro-RNA Function

C72 Sleep And Sleep Disordered Breathing In Other Medical Disorders

C73 Sleep Disordered Breathing: Epidemiology And Outcomes


WS5 Models Of Sleep Apnea Care Utilizing Portable Monitoring And Alternative DeliveryMethods


16 of 24 5/31/2012 5:25 PM

AP

Highlight

AP

Highlight

WS6 Pulmonary Evaluation And Respiratory Support In Amyotrophic Lateral Sclerosis(ALS)


MP601 Stress And Childhood Asthma: Is It Time To Consider Clinical Interventions?

MP602 Publish Without Perishing: A Guide To What Those Darn Editors Want

MP603 Management Of Pulmonary Nodules, Including Nodules Identified During Lung CancerScreening And Ground Glass Opacities

MP604 Drug-Induced/Iatrogenic Respiratory Disease

MP605 Case-Based Approach To Pulmonary Mac and M.Abscessus Infection

MP606 Acute Exacebation Of Idiopathic Pulmonary Fibrosis: Concept And Management

MP607 Therapeutic Bronchoscopy For Benign And Malignant Airway Obstruction: The NutsAnd Bolts

MP608 Pneumonia: From The Emergency Department To The Hospital

MP609 Can ARDS Be Prevented?

MP610 Investigation And Management Of Occupational Asthma

MP611 Management Of Ventilator Associated Pneumonia: State Of The Art From Experts

MP612 Children's Interstitial And Diffuse Lung Disease In The Critical Care Unit

MP613 Management Of Right Heart Failure In The ICU

MP614 The Management of Refractory Dyspnea In Advance COPD

MP615 GM-CSF Inhalation As A Less Invasive Treatment For Pulmonary Alveolar Proteinosis

MP616 Adiponectin In Asthma: Beneficial Role Or Innocent Bystander?

MP617 Continuous Positive Airway Pressure (CPAP) Use In Children

MP618 Updates In Fungal Infections, From Bench To Bedside

MP619 Improving The Early Diagnosis Of Pulmonary Hypertension



YEAR IN REVIEW2:00 pm – 4:30 pm

C81 Nursing Year In Review: Interdisciplinary Research: Moving From Silos To Synergy


C82 Pulmonary And Non-Pulmonary Manifestations Of Hyperinflation In ChronicObstructive Pulmonary Disease: Pathogenesis And Implications For Treatment

C83 Pediatric Clinical Chest Rounds


17 of 24 5/31/2012 5:25 PM

AP

Highlight


C84 Using Genomics To Understand And Treat Acute Lung Injury


C85 Quality And Performance Measures: The Future Of Healthcare

C86 Severe Asthma: A View To The Future Consultation

C87 Hypoxia And Neurocognitive Impairment: Lessons From Sleep Apnea And IschemicBrain Injury

C88 Lung Cancer Stem Cells And The Role Of The Microenvironment In LungCarcinogenesis

C89 Evidence-Based Innovations In Tuberculosis Diagnosis And Treatment

C90 Pro-Con Debate: Comparative Effectiveness Research: Fool's Gold Or Promise Land?


C92 Control Of Macrophage Polarization And Effector Functions

C93 Evolving Role Of Screening For Lung Cancer

C94From Bay To Breaking Intensive Care Unit Capacity: Staffing, Strains And Stemming TheTide

C95 Novel Insights Into Influenza Pathogenesis

C96Bone Marrow And Microparticles In The Pathogenesis Of Pulmonary ArterialHypertension

C97 Mechanism And Outcomes Of Cellular Autophagy

C98 Novel Airway Epithelial Barrier And Immune Responses

C101 Transplant And Ischemia And Reperfusion Related Lung Injury

C102 Quality Improvement In Pulmonary Medicine

C103Pathogenesis, Biomarkers, And Risk Factors For Interstitial Lung Disease: From BenchTo Bedside

C104 Case Reports: Interventional Pulmonology And Pleural Diseases

C105 Ethics And End-Of-Life Care In The Intensive Care Unit

C106 Determinants Of Control And Severity Of Asthma And COPD

C107 Progress In Biomarkers And Diagnostics For Respiratory Infections

C108 Pediatric Cystic Fibrosis And Primary Ciliary Dyskinesia

C109 Effects Of Senescence And Manifestations Of Aging In The Lung

C110Skeletal Muscle Dysfunction In Chronic Pulmonary Disease: Adaptation OrMaladaptation?


18 of 24 5/31/2012 5:25 PM

WEDNESDAY, MAY 23


SS301 Asthma Exacerbations: Risks, Biomarkers And Management Strategies

SS302 Rheumatoid Arthritis Related Interstitial Lung Diseases

SS303 Introduction To Quality Improvement

SS304 Connective Tissue Disease And The Lung: Lessons Learned From Difficult Cases

SS305 Is Sleep Apnea Affecting My Brain? Impact Of OSAS On Neurocognitive Function

SS306 Antisynthetase Syndrome

SS307 Managing Patient Care And Complications After Lung Transplantation

SS308 Mortality And The Cardiovascular Effects Of Acute Exacerbation Of COPD

SS309 Pulmonary Embolism: To Lyse Or Not?

SS310 Are Diseased Airway Epithelial Cells More Susceptible To Air Pollutants?

SS311 Sleep Disordered Breathing In Pediatric Neuromuscular Disease

SS312 Genetics Of Pulmonary Arterial Hypertension: Relevance To Clinical Practice

SS313 Mitochondrial Metabolism: A Novel Therapeutic Target In Chronic Lung Disease

SS314 L-Arginine Homeostasis: Novel Master Switch In Respiratory Structure And Function?

SS315 Stroke As A Sequela Of Sleep Pathology


D1 Clinical Year in Review 4


D2 Mechanisms And Implications Of Mucus Accumulation In Chronic ObstructivePulmonary Disease

D3 The SPN In 2012: The State Of The Art In The Evaluation Of The Pulmonary Nodule


D4 Intensive Care Of The Future


D5 Addressing Variability In Asthma Treatment Responses: Implementing AnIndividualized Approach

D6 Behavioral Sciences Year In Review: Celebrating The BSA's 20th Anniversary

D7 Alveolar Epithelium In Fibrotic Lung Remodeling: Innocent Bystander Or Key Player?


19 of 24 5/31/2012 5:25 PM

D8 Epigenetic Targets For Novel Therapy Of Lung Diseases

D9 Controversies In The Diagnosis And Treatment Of Sickle Cell Lung Disease

D10 Inhaled Exposures, Genetics And Airways Disease: A View Towards Prevention

D11 Critical Care In The Immunocompromised Host

D12 The Changing World Of Drug Discovery And Development


D13 Scientific And Clinical Innovations In Lung Transplantation

D14 Advances In Pleural Infection And Malignancy

D15 Surgical And Bronchoscopic Lung Volume Reduction: State Of The Art

D16 Cystic Fibrosis: Biomarkers, Outcome Measures, And Pathogenesis

D17Sleep Disordered Breathing Pathogenesis: Mechanical And NeuralMechanisms

D18 Sleep Disordered Breathing And Metabolic Function: How Unsweet It Is

D21 Microbial Contributions To Asthma Pathogenesis

D22 Pathogenesis Of Lung Fibrosis And Airway Remodeling

D23 Case Reports: Interstitial Lung Disease

D24 The Villain Behind Ventilator-Induced Lung Injury

D25 Pulmonary Infections And Tuberculosis: Case Reports Of Note

D26 Pediatric Respiratory Infections

D27 Signaling Molecules Involved In Pulmonary Endothelial Injury And Repair

D28 Developmental Signaling Reborn In Adult Lung Disease

D29 Sticky Situation: Multi-Fate Of Cell And Matrix Interactions

D30 Novel Approaches To Assessing Lung Pathophysiology


D31 Advances In Asthma Genetics

D32 Aerosols Therapy

D33 Asthma Pathogenesis

D34 Asthma Epidemiology

D35 Phosphodiesterase Inhibitors As Therapeutics For Lung Diseases

D36 Influences And Outcomes Of Respiratory Viral Infections


20 of 24 5/31/2012 5:25 PM

AP

Highlight

D37 What's New In Fibrosis And Pneumonitis?

D38 Mast Cells And Basophils In Asthma And COPD

D39 Evaluation And Monitoring Of Asthma And COPD

D40 Sepsis

D41Developing And Improving Measures To Assess And Change Beliefs, Skills, BehaviorsAnd Outcomes

D42 COPD Treatment: Oxygen, Home Ventilation And Others

D43 Pulmonary Alveolar Proteinosis

D44 Clinical Application Of Pulmonary Physiological Studies

D45 Acute Exacerbations Of Idiopathic Pulmonary Fibrosis

D46 Case Reports: Lung Transplantation

D47 Issues In Thoracic Surgery

D48 Chronic Cough

D49 Impact Of COPD Exacerbation On Comorbidities

D50 Genetic Studies In COPD

D51 COPD: Diagnosis And Evaluation

D52 Case Reports: Pleural Diseases

D53 Interstitial Lung Disease Case Reports: Sometimes The Hoof Beats Indicate Zebras

D54 Topics In Interventional Pulmonology

D55From The White Elephant To The Common Canary: Presentation And Outcomes OfCommon And Not-So-Common Critical Illnesses

D56 Intensive Care Unit Procedures, Ultrasound, And New Devices

D57 Sepsis: Of Mice, Metabolomics, And Man

D58 Extracorporeal Membrane Oxygenation: Resting Injured Lungs

D59 COPD Epidemiology: Risk Factors, Trends, Comorbidities

D60 Health Effects Of Smoking

D61 Respiratory Clinical Epidemiology

D62 Nosocomial Infections: Bacteriology, Drug Resistance, And Outcomes

D63 Advances In Treatment Of Respiratory Infections

D64 New Insights Into Mechanisms, Complications And Outcomes Of Bronchiectasis

D65 Case Reports Of Unusual Pulmonary Infections

D66 General Pediatric Pulmonary


21 of 24 5/31/2012 5:25 PM

AP

Highlight

AP

Highlight

D67 Pediatric Pulmonary Physiology And Measurement

D68 Pulmonary Vascular Diseases: Clinical Cases

D69 Pulmonary Embolism And Chronic Thromboembolic Pulmonary Hypertension

D70 Mechanical Forces And Hemodynamics In Response To Exercise

D71 Animal Models Of Lung Fibrosis: Bleo And Beyond

D72 Cell Fate Decisions: Apoptosis Vs. Survival Of Structural Cells Of The Lung

D73 Receptor Input Of Airway Networking

D74 Molecular Targets And Model Therapies For Lung Cancer

D75 Mucins: Novel Pathways Of Regulation And Previously Unsuspected Functions

D76 Alveolar Epithelium: Novel Tools And Phenotypes

D77 Airway Cell Differentiation And Injury: Two Sides Of A Coin

D78 Pathways And Models Of Lung Oncogenesis

D79 Exercise, Hypoxia And Altitude

D80 Emphysema And COPD: Pathophysiology

D81 Assessing The Airways

D82A Sleep Disordered Breathing: Diagnosis

D82B Management Of Sleep Disordered Breathing


WS7 Innovative Teaching And Evaluation Methods

WS8 Clinical Impact Of Point Of Care Ultrasonography In Critically Ill Patients


L18 Ancillary Studies Of The American Lung Association Asthma Clinical ResearchCenters

L19 Overview By The Environmental Protection Agency On Recent Actions And TheAgency's Research Program

L20 Counteract Research Program At NIEHS/NIH

L21 U.S. Critical Illness And Injury Trials (USCIIT) Group: Clinical Trials Update

L22 Pulmonary Research At The VA

L23 Idiopathic Pulmonary Fibrosis Network IPFNet: New Insights Into IPF

L24 Major Scientific Advances From NHLBI ARRA-Funded Challenge Grants

L25 Sleep Heart Health Study: Key Discoveries And Scientific Opportunities


22 of 24 5/31/2012 5:25 PM

AP

Highlight

AP

Highlight

L28 ARDS Consensus Conference: New Definition and Disease Stratification


D83 Pneumonia And Pleural Infection: Advances And Controversies


D84 What Are The Boundaries Of Acceptable Medical Practice Near The End Of Life InIntensive Care Units?


D85 Hypersensitivity Pneumonitis: Recent Advances, Future Directions

D86 Impact Of Exercise On Cardiopulmonary Status: Implications For PulmonaryHypertension

D87 Intermittent Hypoxia Mediated Cardiovascular And Neuronal Protective Mechanisms

D88 Imaging Structure And Function Via MRI, CT, And PET

D89 Live And Let Die: Linking Endoplasmatic Stress, Autophagy, And Apoptosis In LungHealth And Disease


D92 Novel Mediators In Asthma Pathogenesis

D93 Early Origins Of Asthma

D94 Non-Invasive Ventilation And Weaning By The Bay

D95 How Do Dietary Factors And Obesity Influence Lung Disease?

D96 What's New In Tuberculosis Diagnostics

D97 Pulmonary Hypertension: New Insights Into Causes And Treatments?

D98Novel Mechanisms Of Tumor Promotion And Molecular Targeted Therapy InLung Cancer

D99Repair By Stem Cells: Paracrine Mechanisms And Induced Pluripotent StemCells (IPSCS)

D100 The Big Role Of Small Airways

D101 Animal Models Of Emphysema

D102 Quality Improvement In Critical Care Medicine

D103 Case Reports: General Pulmonary

D104Connective Tissue Disease Related-Interstitial Lung Disease: Clinical FeaturesAnd Treatment

D105 COPD: Phenotypes And Outcomes

D106 Case Reports: Tumors


23 of 24 5/31/2012 5:25 PM

D107 Pediatric Sleep Disorders

D108 Out Of Control: Proliferative And Fibrotic Remodeling Of The Lung

D109Sleep Disordered Breathing And Heart Failure: Mechanisms, Consequences,And Treatment

"The International Conference is an incredible opportunity for trainees though the sheer size of themeeting can be somewhat intimidating to new attendees. However, the ATS has created

opportunities just for trainees to make the meeting more meaningful, manageable and fun." -Polly Parsons, MD

HOME |ATS Website | Contact Us | News Room Become our Fan on Facebook | Follow us on Twitter

25 Broadway New York, NY 10004-1012 Voice: + 1 (212) 315 - 8600 Fax: + 1 (212) 315 - 6498

Copyright © 2012 American Thoracic Society · Privacy Statement


24 of 24 5/31/2012 5:25 PM

Documents

American Thoracic Society 2012 Sessions